DYNAVAX TECHNOLOGIES

DVAX

Delayed - 01/19 04:00:00 pm
5.1USD	-0.58%

Turn to zoom

Prev.	5.1300
Open	5.1500
High	5.3200
Low	5.0700
Volume	2 583 206

7d ago	DYNAVAX TECHNOLOGIES CORP : Change in Directors or Principal Officers,...
01/07	DYNAVAX TECHNOLOGIES CORP : Other Events (form 8-K)
01/07	Dynavax Technologies : Reports Positive Data From Study of New Four-Dose...
12/29	Health group CEPI to help fund Indian drugmaker's COVID-19 vaccine

	Short Term	Mid-Term	Long Term
Trend	Neutral	Bearish	Neutral
Resistance	5,60	6,01	11,4
Spread/Res.	-8,9%	-15%	-55%
Spread/Supp.	15%	37%	112%
Support	4,45	3,73	2,41

Sales 2020	40,1 M - -
Net income 2020	-87,3 M - -
Net Debt 2020	- - -
P/E ratio 2020	-5,93x
Yield 2020	-

Capitalization	562 M 562 M -
Capi. / Sales 2020	14,0x
Capi. / Sales 2021	4,51x
Nbr of Employees	231
Free-Float	99,2%

Dynavax Technologies Corporation is a clinical-stage immunotherapy company. The Company is focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a...

>> Read more

Sector :

Bio Therapeutic Drugs

Calendar :

2021-03-11 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	BUY
Number of Analysts	4
Average target price	16,00 $
Last Close Price	5,10 $
Spread / Highest target	292%
Spread / Average Target	214%
Spread / Lowest Target	175%